Faller Douglas Vincent 4
4 · Imunon, Inc. · Filed Jun 29, 2026
Research Summary
AI-generated summary of this filing
Imunon (IMNN) CMO Douglas Faller Receives 21,896-Share Award
What Happened
- Douglas Vincent Faller, Chief Medical Officer of Imunon, Inc. (IMNN), was granted 21,896 shares on June 25, 2026. The shares were valued at $1.72 each, for a total reported value of $37,661. This was an award/acquisition (not an open-market purchase or sale).
Key Details
- Transaction date and terms: 2026-06-25 — 21,896 shares @ $1.72 per share (A: award/grant)
- Reported value: $37,661
- Shares owned after transaction: not disclosed in the filing
- Footnote: F1 — stock was granted in lieu of cash for 50% of the 2025 annual cash bonus
- Filing: Form 4 filed 2026-06-29; this filing date is within the typical two-business-day reporting window for a 2026-06-25 transaction (timely)
Context
- This award represents compensation (a bonus paid in stock), which is routine for executives and does not necessarily signal the insider’s personal trading view. Such non-open-market grants are distinct from purchases or sales and mainly reflect company compensation policy rather than a direct buy/sell sentiment.
Insider Transaction Report
Form 4
Imunon, Inc.IMNN
Faller Douglas Vincent
Chief Medical Officer
Transactions
- Award
Common Stock
[F1]2026-06-25$1.72/sh+21,896$37,661→ 21,896 total
Footnotes (1)
- [F1]Stock granted in lieu of cash for 50% of 2025 annual cash bonus
Signature
/s/ Susan Eylward, Attorney-in-Fact for Douglas Faller|2026-06-29